Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pressure on Europe’s drug agencies can be eased through public and private means

This article was originally published in Clinica

Executive Summary

The global economic crisis has placed many European industries under financial pressure. To date, however, the pharmaceutical industry has appeared to be remarkably resilient for one simple reason: society demands health. Yet, whilst the industry has maintained a sense of imperviousness, some of the EU member state medicines agencies – many responsible for regulating both pharmaceuticals and medical devices – are beginning to buckle under the pressure of the economic downturn, coupled with the increasing legislative demands that emanate from Brussels.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045354

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel